$2.15
-0.04-1.83%
At Close: -
$2.13
-0.02-0.92%
After Hours: Sep 20, 7:33 PM EDT
15 minutes delayed
Comments
Loading...
Taysha Gene Therapies (TSHA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTaysha Gene Therapies (NASDAQ:TSHA) Stock Quotes, Forecast and News Summary
Taysha Gene Therapies Stock (NASDAQ: TSHA) stock price, news, charts, stock research, profile.
| Open | $2.20 |
| Close | $2.15 |
| Volume / Avg. | 5.46M / 2.20M |
| Day Range | $2.13 - $2.20 |
| 52 Wk Range | 1.27 - 4.32 |
| Market Cap | $436.59M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 46 |
| Short Interest | 13.94% |
| Days to Cover | 24.68 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Taysha Gene Therapies Inc
Sector
Health Care
Industry
Biotechnology
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disea...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Taysha Gene Therapies (TSHA) stock?
You can purchase shares of Taysha Gene Therapies (NASDAQ:TSHA) through any online brokerage.
Who are Taysha Gene Therapies (TSHA) competitors?
Other companies in Taysha Gene Therapies’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Inozyme Pharma (NASDAQ:INZY), Korro Bio (NASDAQ:KRRO) and Larimar Therapeutics (NASDAQ:LRMR).
What is the forecast, or price target, for Taysha Gene Therapies (TSHA) stock?
Taysha Gene Therapies has a consensus price target of $7.13.
What is the current price for Taysha Gene Therapies (TSHA)?
The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $2.1303 last updated September 20, 2024 at 7:33 PM EDT.
Does Taysha Gene Therapies (TSHA) pay a dividend?
There are no upcoming dividends for Taysha Gene Therapies.
When is Taysha Gene Therapies (NASDAQ:TSHA) reporting earnings?
Taysha Gene Therapies’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Taysha Gene Therapies (TSHA) going to split?
There is no upcoming split for Taysha Gene Therapies.
What sector and industry does Taysha Gene Therapies (TSHA) operate in?
Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.